Dupilumab Phase 4 Study

Clinical trial NCT03411837 · TERMINATED

Trial details

NCT number: NCT03411837
Sponsor: Northwestern University
Status: TERMINATED
Study type: OBSERVATIONAL

Atopic Dermatitis

Start date: 2017-10-16
Primary completion: 2019-08-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.